Relay Therapeutics, Inc.
NASDAQ:RLAY
Overview | Financials
Company Name | Relay Therapeutics, Inc. |
Symbol | RLAY |
Currency | USD |
Price | 6.14 |
Market Cap | 997,510,540 |
Dividend Yield | 0% |
52-week-range | 5.6 - 12.14 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS |
Website | https://www.relaytx.com |
An error occurred while fetching data.
About Relay Therapeutics, Inc.
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD